Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant

American Journal of Perinatology

Volumn 20, Issue 2, 2003, Pages 91-96

  Torres Valdivieso, M J ^a,b   Cobas, J ^b   Barrio, C ^b   Munoz C ^b   Pascual, M ^b   Orbea, C ^b   Rodriguez, E ^b   Gutierrez F ^b  

^a Hospital 12 de Octubre ^*  (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Newborn; Rt PA; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; EXPERIENCE; FEMALE; FIBRINOLYTIC THERAPY; HEART ATRIUM THROMBOSIS; HEART CATHETER; HUMAN; INTENSIVE CARE UNIT; INTRACARDIAC THROMBOSIS; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; THROMBOCYTE COUNT; VEIN THROMBOSIS;

EID: 0037302275     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38343     Document Type: Article

References (23)

1. Lumb PD. Complications of central venous catheters. Crit Care Med 1993;21:1105-1106
2. Schmidt B, Zipensky A. Thrombotic disease in newborn infants. Clin Perinatol 1984;11:461-488
3. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and International Registry. Pediatrics 1995;96:939-943
4. Edstrom C, Christensen R. Evaluation and treatment of thrombosis in the neonatal intensive care unit. Clin Perinatol 2000;27:623-641
5. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 2000;47:763-766
6. Giuffre B, Compagnoni G, Farina C, Mosca F. Succesful use of tissue plasminogen activator (t-PA) in catheterrelated intracardiac thrombi of the premature infants. Acta Paediatr 1998;87:695-698
7. Van Overmeire B, Van Reempts PJ, Van Acker KJ. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator. Arch Dis Child 1992;67:443-444
8. Alkalay A, Mazkereth R, Santulli T, Pomerance J. Central venous line thrombosis in premature infants: a case management and literature review. Am J Perinatol 1993;10:323-326
9. De Schepper J, Hachimi-Idrissi S, Cham B, et al. Diagnosis and management of catheter-related infected intracardiac thrombosis in premature infants. Am J Perinat 1993;10:39-42
10. Schmidt B, Andrew M. Report of scientif and standardization subcommittee on neonatal hemostasis. Diagnosis and treatment of neonatal thrombosis. Thromb Haemost 1992;67:381-382
11. Streif W, Mitchell L, Andrew M. Antithrombotic therapy in children. Curr Opin Pediatr 1999;11:56-64
12. Nowak-Göttl U, Auberger K, Halimeh S, et al. Thrombolysis in newborns and infants. Thromb Haemost 1999; 82(suppl 1):112-116
13. Farnoux C, Camard O, Pinquer D, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1998;133:137-140
14. Weiner G, Castle V, DiPietro M, Faix R. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 1998;133:133-136
15. Weinschenk N, Pelidis M, Fiascone J. Combination thrombolytic and anticoagulant therapy for bilateral renal vein thrombosis in a premature infant. Am J Perinatol 2001;18:293-298
16. Anderson BJ, Keeley SR, Johnson ND. Caval thrombolysis in neonates using low doses of recombinant human tissuetype plasminogen activator. Anaesth Intensive Care 1991;19:22-27
17. Dillon PW, Fox PS, Berg CJ, Cardella JF, et al. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg 1993;28:1264-1269
18. Hartmann J, Hussein A, Trowitzsch E. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001;85:F8-F22
19. Ferrari F, Vagnarelli F, Gargano G, et al. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Child Fetal Neonatal Ed 2001;85:F66-F69
20. Zenz W, Muntean W. Thrombolytic therapy in children: an update. Fibrinolysis 1995;9(suppl):33-36
21. Kennedy LA, Drummond WH, Knight ME, et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr 1990;116:798-801
22. Levy M, Benson LN, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-472
23. Deeg KH, Wolfel D, Rupprecht T. Diagnosis of neonatal aortic thrombosis by colour coded Doppler sonography. Pediatr Radiol 1992;22:62-63